Sec Form 13D Filing - Affinity Partners GP LP filing for - 2025-08-14

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
* Based on 673,556,656 shares of Common Stock outstanding, as disclosed by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the "Q2 10-Q"), filed with the Securities and Exchange Commission ("SEC") on August 14, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
* Based on 673,556,656 shares of Common Stock outstanding, as disclosed by the Issuer in the Q2 10-Q.


SCHEDULE 13D



Comment for Type of Reporting Person:
* Based on 673,556,656 shares of Common Stock outstanding, as disclosed by the Issuer in the Q2 10-Q.


SCHEDULE 13D



Comment for Type of Reporting Person:
* Based on 673,556,656 shares of Common Stock outstanding, as disclosed by the Issuer in the Q2 10-Q.


SCHEDULE 13D



Comment for Type of Reporting Person:
* Based on 673,556,656 shares of Common Stock outstanding, as disclosed by the Issuer in the Q2 10-Q.


SCHEDULE 13D



Comment for Type of Reporting Person:
* Includes 12,111 restricted stock units ("RSUs") that represent a contingent right to receive, upon settlement, one share of Common Stock that vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Mr. Kushner's continued service as a director of the Issuer. Mr. Kushner has agreed to transfer the shares of Common Stock underlying the RSUs that vest and settle to certain of the Affinity funds. Mr. Kushner disclaims beneficial ownership over the shares underlying the RSUs.
 
 ** Based on 673,556,656 shares of Common Stock outstanding, as disclosed by the Issuer in the Q2 10-Q.


SCHEDULE 13D

 
Affinity Partners Fund I LP
 
Signature:/s/ Ian Brekke
Name/Title:Ian Brekke / Authorized Signatory
Date:08/14/2025
 
Affinity Partners Parallel Fund I LP
 
Signature:/s/ Ian Brekke
Name/Title:Ian Brekke / Authorized Signatory
Date:08/14/2025
 
Affinity Partners GP LP
 
Signature:/s/ Ian Brekke
Name/Title:Ian Brekke / Authorized Signatory
Date:08/14/2025
 
Affinity QXO 1 LLC
 
Signature:/s/ Ian Brekke
Name/Title:Ian Brekke / Authorized Signatory
Date:08/14/2025
 
Affinity Partners Fund I Co-Invest GP LP
 
Signature:/s/ Ian Brekke
Name/Title:Ian Brekke / Authorized Signatory
Date:08/14/2025
 
Jared Kushner
 
Signature:/s/ Jared Kushner
Name/Title:Jared Kushner
Date:08/14/2025
primary_doc.xml